Literature DB >> 17315797

Clinical assessment of mineral trioxide aggregate (MTA) as direct pulp capping in young permanent teeth.

Najat Farsi1, Najlaa Alamoudi, Khalid Balto, Abdullah Al Mushayt.   

Abstract

UNLABELLED: Carious pulp exposure in permanent molars of children is a common incident. Mineral trioxide aggregate is a new material that possesses numerous exciting possibilities for pulp therapy. AIM: The purpose of this study was to evaluate the efficiency of MTA as a direct pulp capping agent in young permanent teeth.
METHODS: Thirty asymptomatic permanent molars with pulp exposures were treated by pulp capping using MTA. At each recall (6 12, 18 and 24 months), the teeth were assessed clinically, through pulpal sensitivity tests, as well as radiographically to evaluate periapical healing.
RESULTS: None of the cases reported spontaneous pain at the six months follow up and the pulp showed signs of vitality and absence of periapical radiolucency. At 24 months, the clinical and radiographic success rate was 93% with evidence of continued root growth.
CONCLUSION: Pulp capping with MTA is recommended for teeth with carious pulp exposures specially immature teeth with high potential for healing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17315797     DOI: 10.17796/jcpd.31.2.n462281458372u64

Source DB:  PubMed          Journal:  J Clin Pediatr Dent        ISSN: 1053-4628            Impact factor:   1.065


  21 in total

Review 1.  Mineral trioxide aggregate (MTA): its history, composition, and clinical applications.

Authors:  Peter Z Tawil; Derek J Duggan; Johnah C Galicia
Journal:  Compend Contin Educ Dent       Date:  2015-04

2.  Prognostic factors in direct pulp capping with mineral trioxide aggregate or calcium hydroxide: 2- to 6-year follow-up.

Authors:  Mehmet Kemal Çalışkan; Pelin Güneri
Journal:  Clin Oral Investig       Date:  2016-04-04       Impact factor: 3.573

3.  Dental discoloration caused by bismuth oxide in MTA in the presence of sodium hypochlorite.

Authors:  Marina Angélica Marciano; Marco Antonio Hungaro Duarte; Josette Camilleri
Journal:  Clin Oral Investig       Date:  2015-04-30       Impact factor: 3.573

Review 4.  Clinical and Molecular Perspectives of Reparative Dentin Formation: Lessons Learned from Pulp-Capping Materials and the Emerging Roles of Calcium.

Authors:  Minju Song; Bo Yu; Sol Kim; Marc Hayashi; Colby Smith; Suhjin Sohn; Euiseong Kim; James Lim; Richard G Stevenson; Reuben H Kim
Journal:  Dent Clin North Am       Date:  2017-01

5.  Histological evaluation of hard tissue formation after direct pulp capping with a fast-setting mineral trioxide aggregate (RetroMTA) in humans.

Authors:  Till Dammaschke; Alicja Nowicka; Mariusz Lipski; Domenico Ricucci
Journal:  Clin Oral Investig       Date:  2019-03-12       Impact factor: 3.573

Review 6.  Keys to clinical success with pulp capping: a review of the literature.

Authors:  Thomas J Hilton
Journal:  Oper Dent       Date:  2009 Sep-Oct       Impact factor: 2.440

7.  Reparative dentinogenesis induced by mineral trioxide aggregate: a review from the biological and physicochemical points of view.

Authors:  Takashi Okiji; Kunihiko Yoshiba
Journal:  Int J Dent       Date:  2009-12-28

Review 8.  Therapeutic potential of mesenchymal stem cells for oral and systemic diseases.

Authors:  Reuben H Kim; Shebli Mehrazarin; Mo K Kang
Journal:  Dent Clin North Am       Date:  2012-07

9.  Evaluation of mineral trioxide aggregate (MTA) versus calcium hydroxide cement (Dycal(®) ) in the formation of a dentine bridge: a randomised controlled trial.

Authors:  Fatou Leye Benoist; Fatou Gaye Ndiaye; Abdoul Wakhabe Kane; Henri Michel Benoist; Pierre Farge
Journal:  Int Dent J       Date:  2012-02       Impact factor: 2.607

10.  A comparative study on dental pulp response to calcium hydroxide, white and grey mineral trioxide aggregate as pulp capping agents.

Authors:  Ali Eskandarizadeh; Mohammad Hossein Shahpasandzadeh; Mahdieh Shahpasandzadeh; Molok Torabi; Masoud Parirokh
Journal:  J Conserv Dent       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.